These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 18322405)

  • 1. Effects of aging on neuroprotective and neurotoxic properties of microglia in neurodegenerative diseases.
    Sawada M; Sawada H; Nagatsu T
    Neurodegener Dis; 2008; 5(3-4):254-6. PubMed ID: 18322405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Sawada H; Hishida R; Hirata Y; Ono K; Suzuki H; Muramatsu S; Nakano I; Nagatsu T; Sawada M
    J Neurosci Res; 2007 Jun; 85(8):1752-61. PubMed ID: 17469135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective and neurotoxic phenotypes of activated microglia in neonatal mice with respective MPTP- and ethanol-induced brain injury.
    Sawada H; Suzuki H; Nagatsu T; Sawada M
    Neurodegener Dis; 2010; 7(1-3):64-7. PubMed ID: 20173329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormones are key actors in gene x environment interactions programming the vulnerability to Parkinson's disease: glia as a common final pathway.
    Marchetti B; Serra PA; L'Episcopo F; Tirolo C; Caniglia S; Testa N; Cioni S; Gennuso F; Rocchitta G; Desole MS; Mazzarino MC; Miele E; Morale MC
    Ann N Y Acad Sci; 2005 Dec; 1057():296-318. PubMed ID: 16399902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone-marrow-derived cell differentiation into microglia: a study in a progressive mouse model of Parkinson's disease.
    Rodriguez M; Alvarez-Erviti L; Blesa FJ; Rodríguez-Oroz MC; Arina A; Melero I; Ramos LI; Obeso JA
    Neurobiol Dis; 2007 Dec; 28(3):316-25. PubMed ID: 17897835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease.
    Kim S; Moon M; Park S
    J Endocrinol; 2009 Sep; 202(3):431-9. PubMed ID: 19570816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases.
    Walker DG; Lue LF
    J Neurosci Res; 2005 Aug; 81(3):412-25. PubMed ID: 15957156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of pro-inflammatory cytokines and microglia in an age-associated neurodegeneration model, the SAMP10 mouse.
    Kumagai N; Chiba Y; Hosono M; Fujii M; Kawamura N; Keino H; Yoshikawa K; Ishii S; Saitoh Y; Satoh M; Shimada A; Hosokawa M
    Brain Res; 2007 Dec; 1185():75-85. PubMed ID: 17949696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective and toxic changes in microglia in neurodegenerative disease.
    Sawada M
    Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S39-41. PubMed ID: 19131042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation in Parkinson's disease: causative or epiphenomenal?
    Hald A; Van Beek J; Lotharius J
    Subcell Biochem; 2007; 42():249-79. PubMed ID: 17612055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excitatory amino acid transporter expression by astrocytes is neuroprotective against microglial excitotoxicity.
    Liang J; Takeuchi H; Doi Y; Kawanokuchi J; Sonobe Y; Jin S; Yawata I; Li H; Yasuoka S; Mizuno T; Suzumura A
    Brain Res; 2008 May; 1210():11-9. PubMed ID: 18410911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous risk factors in Parkinson's disease: dopamine and tetrahydroisoquinolines.
    Antkiewicz-Michaluk L
    Pol J Pharmacol; 2002; 54(6):567-72. PubMed ID: 12866710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation, the complement system and the diseases of aging.
    McGeer EG; Klegeris A; McGeer PL
    Neurobiol Aging; 2005 Dec; 26 Suppl 1():94-7. PubMed ID: 16198446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation.
    Teismann P; Schulz JB
    Cell Tissue Res; 2004 Oct; 318(1):149-61. PubMed ID: 15338271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoactive intestinal peptide prevents activated microglia-induced neurodegeneration under inflammatory conditions: potential therapeutic role in brain trauma.
    Delgado M; Ganea D
    FASEB J; 2003 Oct; 17(13):1922-4. PubMed ID: 12923064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broad neuroprotective profile of nicotinamide in different mouse models of MPTP-induced parkinsonism.
    Anderson DW; Bradbury KA; Schneider JS
    Eur J Neurosci; 2008 Aug; 28(3):610-7. PubMed ID: 18702732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurodegenerative alterations induced by MPTP neurotoxin in senescence accelerated mice essay].
    Fedorova TN; Stvolinskiĭ SL; Bagyeva GH; Ivanova-Smolenskaia IA; Illarioshkin SN
    Usp Fiziol Nauk; 2005; 36(2):94-101. PubMed ID: 15909667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glial cells as players in parkinsonism: the "good," the "bad," and the "mysterious" glia.
    Mena MA; García de Yébenes J
    Neuroscientist; 2008 Dec; 14(6):544-60. PubMed ID: 19029058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining "neuroinflammation".
    O'Callaghan JP; Sriram K; Miller DB
    Ann N Y Acad Sci; 2008 Oct; 1139():318-30. PubMed ID: 18991877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Damage to the nigrostriatal system in the MPTP-treated SAMP8 mouse.
    Liu J; Wang YY; Liu L; Wang QD; Yuan ZY; Zhang ZX; Gu P; Wang MW
    Neurosci Lett; 2008 Dec; 448(2):184-8. PubMed ID: 18977411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.